Protective effect of melatonin on injured cerebral neurons is associated with bcl-2 protein over-expression

Acta Pharmacologica Sinica

Volumn 20, Issue 5, 1999, Pages 409-414

  Ling, Xiang ^a   Zhang, Ling Mei ^a   Lu, Shi Duo ^a   Li, Xue Jun ^a   Sun, Feng Yan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

bax; Cerebral arteries; Cerebral ischemia; Free radicals; Immunohistochemistry; Melatonin; Proto oncogene proteins c bcl 2

Indexed keywords

MELATONIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NONHUMAN; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN ISCHEMIA; MALE; MELATONIN; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0033005001     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 125I-Superoxide dismutase in mice. Res Commun Chem Pathol Pharmacol 1976; 15: 641-54.
2. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55: 271-6.
3. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, box, that accelerates programmed cell death. Cell'1993; 74: 609-19.
4. Chen J, Graham SH, Chan PH, Lan J, Zhou RL , Simon RP. bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport 1995; 6: 394-8.
5. Li XJ, Zhang LM, Gu J, Zhang AZ, Sun FY. Melatonin decreases production of hydroxyl radical during cerebral ischemia-reperfusion. Acta Pharmacol Sin 1997; 18: 394-6.
6. Aronowski J, Strong R, Grotta JC. Combined neuroprotection and reperfusion therapy for stroke. Stroke 1996; 27: 1571-6.
7. Fiorina P, Lattuada G, Ponari O, Silvestrini C, DallAglio P. Impared nocturnal melatonin excretion and changes of immunological status in ischemi stroke patients. Lancet 1996; 347: 692-3.
8. Manev H, Uz T, Kharlamov A, Joo JY. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 1996; 10: 1516-51.
9. Unlap T, Jope RS. Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Brain Res Mol Brain Res 1995; 28: 193-200.
10. Nicholson DW, Thornberry NA. Caspases; killer proteases. Trends Biochem Sci 1997; 22: 299-306.
11. Merry DE, Korsmeyer SJ. bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997; 20: 245-67.
12. Yin XM, Oltvai ZN, Korsmeyer SJ. Bhl and Bh2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with box. Nature 1994; 369: 321-3.
13. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for bcl-XL and bcl-2, displace box and promotes cell death. Cell 1995; 80: 285-91.
14. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, et al. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993; 90: 4533-7.
15. Kane DJ, Sarafian TA, Auton S, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-7.